查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1347709

心臟假体设备市场：2023-2028 年全球行业趋势、份额、规模、增长、机会和预测

Cardiac Prosthetic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2023-2028 年市场概览：

2022年，全球心臟假体器械市场规模达到62亿美元。展望未来，IMARC集团预计到2028年市场规模将达到100亿美元，2023-2028年復合年增长率（CAGR）为8.1%。紧凑型起搏器和免缝合瓣膜置换术的发展、微创（MI）手术的日益增长以及大众心血管疾病患病率的上升是推动该市场的一些主要因素。

心臟假体装置是指设计用于替代或辅助心臟正常功能的人造装置或植入物。它们用于治疗各种心臟疾病，例如心力衰竭、瓣膜疾病或先天性心臟缺陷。它们大致可分为两种类型：人工心臟瓣膜和机械循环支持装置。人造心臟瓣膜用于替换受损或患病的心臟瓣膜，恢復流经心臟的正常血流。另一方面，机械循环支持装置用于辅助或替代心臟的泵血功能，通常用作移植的桥樑或作为不适合心臟移植的患者的长期解决方案。此外，它们由生物相容性材料製成，经过精心设计，可复制心臟的结构和功能，从而改善患者的心臟功能和生活质量。

该行业是由全球人口老龄化推动的。随着人口持续老龄化，心血管疾病的发病率增加，导致对心臟假体装置的需求更高。此外，医疗技术和外科技术的不断进步提高了心血管疾病患者的生存率，这为这些设备创造了更大的患者库。与此同时，大众对心血管健康的认识不断提高以及治疗方案的可用性正在推动产品需求。此外，患者正在寻求及时的干预措施，包括使用心臟假体装置，以提高生活质量并延长生存期，这对市场产生了积极影响。其他因素，包括医疗保健行业的持续发展以及主要参与者进行的广泛研发（R＆D）活动，也对市场产生积极影响。

心臟假体设备市场趋势/驱动因素：

心血管疾病的患病率及其意识的提高

心血管疾病，包括冠状动脉疾病、心力衰竭和瓣膜性心脏病，是全球发病率和死亡率的重要原因。此外，人们对心脏病、预防措施和治疗方案的认识不断提高，从而可以更早地发现和诊断心血管疾病。诊断能力的提高，包括超声心动图和心臟 MRI 等先进成像技术，有助于准确诊断和识别可能受益于心臟假体装置的患者。公众意识的提高和多种疾病患病率的上升共同导致了产品需求的增加。随着越来越多的人在早期被诊断出患有心血管疾病，越来越多的患者可以从涉及心臟修復术的干预措施中受益。

落实优惠报销政策

报销在心臟假体装置的采用中发挥着至关重要的作用。政府医疗保健系统和私人保险提供商提供的优惠报销政策激励医疗保健提供商向患者提供这些设备和程序。这为市场增长创造了有利的环境，因为它减少了患者的经济障碍并促进了心臟假体设备的使用。此外，不断增加的疾病负担和医疗技术的进步正在增加全球的医疗保健支出。医疗保健支出的增加有助于提高心臟假体设备的可负担性和可及性，从而使有需要的患者能够更广泛地获得它们。除此之外，市场参与者正在建立伙伴关係、协作和分销网络，这是另一个增长诱导因素。

心臟手术技术和设备的持续技术创新

心臟外科技术的不断进步，如微创手术、机器人辅助手术和经导管介入治疗，扩大了治疗各种心臟疾病的范围。这些进步提高了产品的利用率，包括心臟瓣膜、心室辅助装置 (VAD) 和起搏器，因为它们在这些手术中发挥着至关重要的作用。技术的快速进步彻底改变了心臟假体设备的设计和功能。例如，经导管心臟瓣膜的发展使得微创瓣膜置换手术成为可能，减少了患者的创伤和恢復时间。此外，起搏器和植入式心律转復除颤器 (ICD) 中无线连接、远程监控功能和先进传感器的集成改善了患者护理和结果，创造了积极的市场前景。

心臟假体器械行业细分：

IMARC Group 提供了全球心臟假体设备报告各个部分的主要趋势分析，以及 2023 年至 2028 年全球、区域和国家层面的预测。我们的报告根据产品类型和最终用户对市场进行了分类。

按产品类型划分：

阀门

机械阀

组织阀

支架组织瓣膜

无支架组织瓣膜

经导管瓣膜

起搏器

植入式起搏器

单室电池起搏器

双室电池起搏器

三室电池起搏器

体外起搏器

其他的

阀门主导市场

该报告根据产品类型对市场进行了详细的细分和分析。这包括瓣膜（机械瓣膜、组织瓣膜、带支架组织瓣膜、无支架组织瓣膜和经导管瓣膜）、起搏器、植入式起搏器（单腔电池起搏器、双腔电池起搏器和三腔电池起搏器）、体外起搏器， 和别的。根据该报告，阀门代表了最大的细分市场。

阀门设计和材料的持续技术进步提高了设备​​的耐用性、功能和整体性能，从而获得了更大的接受和采用。此外，对微创手术的日益关注和经导管心臟瓣膜置换技术的发展正在积极影响对瓣膜产品的需求。

此外，医疗技术的不断进步促进了创新起搏器设备的开发，这些设备具有改进的特性和功能，包括无线连接和远程监控功能，这进一步推动了市场增长。此外，肥胖和糖尿病等与生活方式相关的疾病患病率不断上升，这些疾病是心脏病的危险因素，正在推动全球对起搏器的需求。

按最终用户划分：

医院、诊所和心臟中心

门诊手术中心

其他的

医院、诊所和心臟中心占据最大的市场份额

报告还提供了基于最终用户的详细市场细分和分析。这包括医院、诊所和心臟中心、门诊手术中心等。报告称，医院、诊所和心臟中心占据了最大的市场份额。

这些设备在医院、诊所和心臟中心的使用越来越多，可归因于医疗技术和外科技术的不断进步。人造心臟瓣膜和植入式起搏器等创新设备的不断发展，使医疗保健提供者能够为患者提供改进的治疗选择。此外，旨在加强心血管护理和改善患者治疗效果的各种政府倡议和医疗改革也成为该行业最终用户的主要市场驱动力。

相反，门诊手术中心（ASC）作为心臟领域的最终用户提供了许多优势，例如成本效益、便利性和减少住院时间，这对寻求心臟手术的患者特别有吸引力。这些中心为微创手术和门诊治疗提供了合适的环境，符合基于价值的医疗保健日益增长的趋势。此外，技术的进步使得在 ASC 中执行复杂的心臟手术成为可能，从而进一步推动了预测期内该领域的市场需求。

按地区划分：

北美

美国

加拿大

亚太地区

中国

日本

印度

韩国

澳大利亚

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉美

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的心臟假体设备市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳大利亚、印尼等）；欧洲（德国、法国、英国、意大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。

北美市场的驱动力是心血管疾病患病率的增加和人口老龄化的加剧。随着心臟相关疾病变得越来越普遍，对心臟瓣膜、起搏器和植入式除颤器等设备的需求不断增长。此外，该地区的医疗保健系统专注于高质量的医疗保健服务，并且对医疗设备的报销支持也在市场的增长中发挥着重要作用。此外，旨在开发创新和微创假肢装置的研发工作正在大力支持市场。

相反，由于人口老龄化和生活方式的改变，亚太地区预计未来几年该领域将进一步扩张。与此同时，亚太地区一些国家医疗基础设施的进步和可支配收入的增加改善了医疗服务的可及性并提高了负担能力。此外，该领域持续的技术进步和创新正在推动亚太地区的市场。

竞争格局：

由于医疗技术和外科手术的不断进步，导致创新和更高效的设备的开发，市场正在经历显着增长。此外，数字健康技术的集成为公司提供远程监控解决方案和个性化医疗服务、改善患者治疗效果并提高其产品的整体价值主张创造了机会。此外，许多公司正在开发定制解决方案来满足特定患者的需求，这在全球范围内越来越受到重视。此外，3D打印技术的发展进一步促进了患者专用设备的生产，从而实现更好的贴合性和改进的功能。此外，顶级公司正在投资研发以创建可定制的解决方案，并与医疗保健专业人员合作以了解患者的需求，这正在影响市场。

该报告对市场竞争格局进行了全面分析。还提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

雅培实验室

百多力

波士顿科学公司

爱德华兹生命科学公司

乐普医疗科技有限公司

美敦力公司

梅里尔生命科学列兵。有限公司

西门子医疗保健有限公司

索林集团

圣裘德医疗公司

最近的发展：

2021 年 9 月，雅培实验室宣布该公司的 Epic Plus 和 Epic Plus Supra 支架组织瓣膜已获得 FDA 批准，扩大了主动脉瓣或二尖瓣功能障碍患者的治疗选择。

2020年1月，美敦力公司宣布其Cobalt和Crome心臟再同步治疗除颤器（CRT-D）和植入式心臟復律除颤器（ICD）获得欧盟CE标誌认证，允许其进入欧洲大陆。

2019年6月，百多力宣布推出其着名的注射式心臟监测仪BIOMONITOR的新型号。虽然 BIOMONITOR III 比 BIOMONITOR 2 小得多，但它提供了更清晰的信号质量。

本报告回答的关键问题：

  • 迄今为止，全球心臟假体设备市场表现如何，未来几年将如何表现？
  • 全球心臟假体器械市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球心臟假体器械市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的心臟假体设备市场？
  • 根据产品类型分類的市场是怎样的？
  • 心臟假体器械市场中最具吸引力的产品类型是什么？
  • 基于最终用户的市场细分是什么？
  • 哪一个是心臟假体设备市场中最具吸引力的最终用户？
  • 全球心臟假体器械市场的竞争结构如何？
  • 全球心臟假体器械市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球心臟假体设备市场表现如何，未来几年将如何表现？
  • 全球心臟假体器械市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球心臟假体器械市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的心臟假体设备市场？
  • 根据产品类型分類的市场是怎样的？
  • 心臟假体器械市场中最具吸引力的产品类型是什么？
  • 基于最终用户的市场细分是什么？
  • 哪一个是心臟假体设备市场中最具吸引力的最终用户？
  • 全球心臟假体器械市场的竞争结构如何？
  • 全球心臟假体器械市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围和方法

  • 研究目的
  • 利益相关者
  • 数据源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球心臟假体器械市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品类型分類的市场细分

  • 阀门
    • 市场走向
    • 主要类型
      • 机械阀
      • 组织阀
      • 支架组织瓣膜
      • 无支架组织瓣膜
      • 经导管瓣膜
    • 市场预测
  • 起搏器
    • 市场走向
    • 市场预测
  • 植入式起搏器
    • 市场走向
    • 主要类型
      • 单室电池起搏器
      • 双室电池起搏器
      • 三室电池起搏器
    • 市场预测
  • 体外起搏器
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：最终用户的市场细分

  • 医院、诊所和心臟中心
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按地区分類的市场细分

  • 北美
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳大利亚
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉美
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Lepu Medical Technology Co. Ltd.
    • Medtronic Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Siemens Healthcare GmbH
    • Sorin Group
    • St. Jude Medical Inc.
Product Code: SR112023A2037

Market Overview 2023-2028:

The global cardiac prosthetic devices market size reached US$ 6.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028. The development of compact pacemakers and suture-less valve replacements, the growing inclination toward minimally invasive (MI) procedures, and the rising prevalence of cardiovascular disorders among the masses are some of the major factors propelling the market.

Cardiac prosthetic devices refer to artificial devices or implants designed to replace or assist the normal functioning of the heart. They are used in the treatment of various heart conditions, such as heart failure, valve disorders, or congenital heart defects. They can be broadly categorized into two types, artificial heart valves and mechanical circulatory support devices. Artificial heart valves are used to replace damaged or diseased heart valves, restoring normal blood flow through the heart. On the other hand, mechanical circulatory support devices are used to assist or replace the pumping function of the heart, often employed as a bridge to transplantation or as a long-term solution for patients ineligible for heart transplantation. Additionally, they are manufactured of biocompatible materials and are meticulously designed to replicate the structure and function of the heart, thereby improving the patient's cardiac function and quality of life.

The industry is driven by the aging global population. As the population continues to age, the incidence of cardiovascular diseases increases, leading to a higher demand for cardiac prosthetic devices. Additionally, continual advancements in medical technology and surgical techniques have improved the survival rates of patients with cardiovascular diseases, this is creating a larger patient pool for these devices. Along with this, the increasing awareness about cardiovascular health and the availability of treatment options among the masses is fueling the product demand. Also, patients are seeking timely interventions, including the use of cardiac prosthetic devices, to improve their quality of life and prolong survival, which is positively influencing the market. Other factors, including continual developments in the healthcare sector and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market.

Cardiac Prosthetic Devices Market Trends/Drivers:

Increasing Prevalence of Cardiovascular Diseases and their Awareness

Cardiovascular diseases, including coronary artery disease, heart failure, and valvular heart diseases, are significant contributors to morbidity and mortality across the globe. Additionally, the increasing awareness about heart diseases, preventive measures, and the availability of treatment options has led to earlier detection and diagnosis of cardiovascular conditions. Improved diagnostic capabilities, including advanced imaging techniques, such as echocardiography and cardiac MRI, facilitate accurate diagnosis and identification of patients who may benefit from cardiac prosthetic devices. The combination of public awareness and the rising prevalence of numerous diseases has led to an increasing product demand. As more individuals are diagnosed with CVDs at an earlier stage, there is a growing pool of patients who could benefit from interventions involving cardiac prosthetics.

The Implementation of Favorable Reimbursement Policies

Reimbursement plays a vital role in the adoption of cardiac prosthetic devices. Favorable reimbursement policies offered by government healthcare systems and private insurance providers incentivize healthcare providers to offer these devices and procedures to their patients. This creates a conducive environment for market growth, as it reduces financial barriers for patients and promotes the use of cardiac prosthetic devices. In addition, the rising disease burden, and advances in medical technology are increasing healthcare expenditure across the globe. This higher healthcare spending is contributing to the affordability and accessibility of cardiac prosthetic devices, making them more widely available to patients in need. Besides this, market players are establishing partnerships, collaborations, and distribution networks, which are acting as another growth-inducing factor.

Continual Technological Innovations in Cardiac Surgery Techniques and Devices

Continuous advancements in cardiac surgical techniques, such as minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions, have expanded the scope of treating various cardiac conditions. These advancements have increased product utilization, including heart valves, ventricular assist devices (VADs), and pacemakers, as they play a crucial role in these procedures. Rapid advancements in technology have revolutionized the design and functionality of cardiac prosthetic devices. For instance, the development of transcatheter heart valves has enabled less invasive valve replacement procedures, reducing patient trauma and recovery time. Additionally, the integration of wireless connectivity, remote monitoring capabilities, and advanced sensors in pacemakers and implantable cardioverter-defibrillators (ICDs) has improved patient care and outcomes, creating a positive market outlook.

Cardiac Prosthetic Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac prosthetic devices report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type and end-user.

Breakup by Product Type:

Valves

Mechanical Valve

Tissue Valve

Stented Tissue Valve

Stentless Tissue Valve

Transcatheter Valve

Pacemakers

Implantable Pacemakers

Single-Chamber Battery Pacemaker

Dual-Chamber Battery Pacemaker

Triple-Chamber Battery Pacemaker

External Pacemakers

Others

Valves dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes valves (mechanical valve, tissue valve, stented tissue valve, stentless tissue valve, and transcatheter valve), pacemakers, implantable pacemakers (single-chamber battery pacemaker, dual-chamber battery pacemaker, and triple-chamber battery pacemaker), external pacemakers, and others. According to the report, valves represented the largest segment.

Continual technological advancements in valve design and materials have improved the durability, functionality, and overall performance of devices, leading to greater acceptance and adoption. Additionally, the increasing focus on minimally invasive procedures and the development of transcatheter heart valve replacement techniques are positively influencing the demand for valve products.

Additionally, continuous advancements in medical technology have led to the development of innovative pacemaker devices with improved features and functionalities, including wireless connectivity and remote monitoring capabilities, which further drive market growth. Moreover, the rising prevalence of lifestyle-related diseases, such as obesity and diabetes, which are risk factors for heart ailments, is fueling the demand for pacemakers across the globe.

Breakup by End-User:

Hospitals, Clinics and Cardiac Centers

Ambulatory Surgical Centers

Others

Hospitals, clinics and cardiac centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospitals, clinics and cardiac centers, ambulatory surgical centers, and others. According to the report, hospitals, clinics, and cardiac centers accounted for the largest market share.

The increasing usage of these devices in hospitals, clinics, and cardiac centers can be attributed to the continual advancements in medical technology and surgical techniques. The continuous development of innovative devices, such as artificial heart valves and implantable pacemakers, enables healthcare providers to offer improved treatment options to patients. Furthermore, various government initiatives and healthcare reforms aimed at enhancing cardiovascular care and improving patient outcomes also serve as major market drivers for the end-users in the industry.

On the contrary, ambulatory surgical centers (ASCs) as end-users in the cardiac offer numerous advantages, such as cost-effectiveness, convenience, and reduced hospital stays, which are particularly appealing to patients seeking cardiac procedures. These centers provide a suitable environment for minimally invasive surgeries and outpatient treatments, aligning with the growing trend towards value-based healthcare. Additionally, advancements in technology have made it feasible to perform complex cardiac procedures in ASCs, further fueling the market demand in this segment over the forecast period.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest the cardiac prosthetic devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The market in North America is driven by the increasing prevalence of cardiovascular diseases and the growing aging population. As heart-related conditions become more common, the need for devices such as heart valves, pacemakers, and implantable defibrillators is growing. Additionally, the healthcare system across the region focuses on quality healthcare delivery and reimbursement support for medical devices also plays a significant role in the growth of the market. Moreover, research and development efforts aimed at developing innovative and minimally invasive prosthetic devices are significantly supporting the market.

On the contrary, Asia Pacific is estimated to expand further in this domain in the coming years due to the aging population and changing lifestyles. In confluence with this, advancements in healthcare infrastructure and the rising disposable income in several countries within the Asia Pacific region have improved access to medical treatments and increased affordability. Furthermore, ongoing technological advancements and innovations in the field are driving the market in Asia Pacific.

Competitive Landscape:

The market is experiencing significant growth due to the continual advancements in medical technology and surgical procedures leading to the development of innovative and more efficient devices. Additionally, the integration of digital health technologies is creating opportunities for companies to offer remote monitoring solutions and personalized healthcare services, enhancing patient outcomes and increasing the overall value proposition of their products. Also, numerous companies are developing tailored solutions to address specific patient needs, this is gaining prominence across the globe. Moreover, the development of 3D printing technology has further facilitated the production of patient-specific devices, allowing for better fit and improved functionality. Additionally, top companies are investing in research and development to create customizable solutions and collaborate with healthcare professionals to understand patient requirements, which is influencing the market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Biotronik

Boston Scientific Corporation

Edwards Lifesciences Corporation

Lepu Medical Technology Co. Ltd.

Medtronic Inc.

Meril Life Sciences Pvt. Ltd.

Siemens Healthcare GmbH

Sorin Group

St. Jude Medical Inc.

Recent Developments:

In September 2021, Abbott Laboratories announced that the company's Epic Plus and Epic Plus Supra Stented Tissue Valves have received FDA approval, expanding treatment options for patients with aortic or mitral valve dysfunction.

In January 2020, Medtronic Inc. announced that its Cobalt and Crome cardiac resynchronization therapy-defibrillators (CRT-D) and implanted cardioverter-defibrillators (ICD) received EU CE Mark certification, permitting their entry to the continent.

In June 2019, Biotronik announced the release of a new model of its well-known injectable heart monitor, BIOMONITOR. While being significantly smaller than the BIOMONITOR 2, the BIOMONITOR III provides a substantially crisper signal quality.

Key Questions Answered in This Report:

  • How has the global cardiac prosthetic devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cardiac prosthetic devices market?
  • What is the impact of each driver, restraint, and opportunity on the global cardiac prosthetic devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive cardiac prosthetic devices market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the cardiac prosthetic devices market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the cardiac prosthetic devices market?
  • What is the competitive structure of the global cardiac prosthetic devices market?
  • Who are the key players/companies in the global cardiac prosthetic devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Prosthetic Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Valves
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Mechanical Valve
      • 6.1.2.2 Tissue Valve
      • 6.1.2.3 Stented Tissue Valve
      • 6.1.2.4 Stentless Tissue Valve
      • 6.1.2.5 Transcatheter Valve
    • 6.1.3 Market Forecast
  • 6.2 Pacemakers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Implantable Pacemakers
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Single-Chamber Battery Pacemaker
      • 6.3.2.2 Dual-Chamber Battery Pacemaker
      • 6.3.2.3 Triple-Chamber Battery Pacemaker
    • 6.3.3 Market Forecast
  • 6.4 External Pacemakers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals, Clinics and Cardiac Centers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ambulatory Surgical Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Biotronik
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Edwards Lifesciences Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Lepu Medical Technology Co. Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Medtronic Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Meril Life Sciences Pvt. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Siemens Healthcare GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Sorin Group
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 St. Jude Medical Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiac Prosthetic Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Prosthetic Devices Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Cardiac Prosthetic Devices Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Cardiac Prosthetic Devices Market: Breakup by End-User (in %), 2022
  • Figure 5: Global: Cardiac Prosthetic Devices Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 7: Global: Cardiac Prosthetic Devices (Valves) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Cardiac Prosthetic Devices (Valves) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Cardiac Prosthetic Devices (Pacemakers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Cardiac Prosthetic Devices (Pacemakers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Cardiac Prosthetic Devices (External Pacemakers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Cardiac Prosthetic Devices (External Pacemakers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: North America: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: North America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: United States: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: United States: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Canada: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Canada: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Asia Pacific: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Asia Pacific: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: China: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: China: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Japan: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Japan: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: India: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: India: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: South Korea: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: South Korea: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Australia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Australia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Indonesia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Indonesia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Europe: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Europe: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Germany: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Germany: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: France: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: France: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: United Kingdom: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: United Kingdom: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Italy: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Italy: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Spain: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Spain: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Russia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Russia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Latin America: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Latin America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Brazil: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Brazil: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Mexico: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Mexico: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Middle East and Africa: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Middle East and Africa: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Global: Cardiac Prosthetic Devices Industry: SWOT Analysis
  • Figure 72: Global: Cardiac Prosthetic Devices Industry: Value Chain Analysis
  • Figure 73: Global: Cardiac Prosthetic Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Prosthetic Devices Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 4: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Cardiac Prosthetic Devices Market: Competitive Structure
  • Table 6: Global: Cardiac Prosthetic Devices Market: Key Players